Related Experiment Video
Updated: Oct 1, 2026

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
Published on: October 6, 2023
A new United States Pharmacopeia (USP) Chapter 1046: cell and gene therapy products
1Seaver Associates, Concord, MA 01742, USA.
Abstract:
The United States Pharmacopeia (USP) has published the first draft of a new information chapter on cell and gene therapy products in January, 2000. The chapter discusses the manufacturing and testing cell and gene therapy products. It is intended for people working in the field as well as for pharmacists and clinicians who would like more information on this subject. This article outlines the background of USP and explains how it became involved with cell and gene therapy and what an information chapter is. It details the subjects covered by the chapter and the philosophy behind the chapter. This draft will be revised based on comments received from the public and then published as a revision subject to further comments before it becomes an official chapter in a supplement to USP 24-NF 19.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Gene Therapy
Cell Lines
Microorganisms in Medicine and Therapeutics
Clinically Relevant Drug Product Specifications: Methods of Establishment
iPS Cell Differentiation

